CClinicalTrials.gg
CompletedNCT04330365wHOPEUpdated Jun 2, 2026Results posted

Pragmatic Trial of WHT vs. PC-GE to Promote Non-Pharmacological Strategies to Treat Chronic Pain in Veterans

An interventional study of Whole Health Team (WHT) Intervention Arm, Primary Care Group Education (PC-GE) Intervention Arm, Usual Primary Care (UPC) Arm in Chronic Pain, sponsored by San Francisco Veterans Affairs Medical Center. Completed at 6 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-02.

Sponsored by San Francisco Veterans Affairs Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
793
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The overarching goal of this Pain Management Collaboratory Demonstration project is to test a new Whole Health paradigm for chronic pain care, emphasizing non-pharmacological pain self-management that is hypothesized to reduce pain symptoms and improve overall functioning and quality of life in Veterans. In UH3 Aim 1, the investigators will conduct a 12-month pragmatic effectiveness trial at 6 VA sites across the country to test whether veterans with moderate to severe chronic pain randomized to receive the Whole Health Team (WHT) intervention are more likely than those receiving Primary Care Group Education (PC-GE) to: Hypothesis 1: Experience improved pain interference (primary outcome), pain intensity, functioning and quality of life (secondary outcomes); Hypothesis 2: Decrease use of higher-risk pain medications, including opioids, or high-risk combinations; Hypothesis 3: Engage in a greater number of non-pharmacological pain management activities; and Hypothesis 4: Experience improved mental health-related symptoms, including sleep problems and suicidality. In addition, both the WHT and PC-GE arms will be compared to a third group of veterans randomized to Usual Primary Care (UPC, Control) on the same primary and secondary outcomes above. After the baseline assessment, masked telephone assessments will be administered to participants at 3, 6, 9, and 12 months. UH3 Aim 2 is to conduct a process evaluation of the two active interventions (WHT and PC-GE) and a budget impact analysis that includes costs to implement and execute the two active interventions as well as the control condition (UPC) to inform the development of an implementation toolkit for scaling and dissemination. Eligible participants are veterans reporting moderate to severe chronic pain present every day or nearly every day for ≥ 6 months. The total sample size for the population is based on our main study aim/hypothesis and is N=764. This breaks down to n=343 in the WHT intervention, n=339 in the PC-GE intervention, and N=82 in the Usual Primary Care arm (Control). Results of this UG3/UH3 Pain Management Collaboratory Demonstration project will contribute to the overall mission of the NIH/VA/DoD initiative to build national-level infrastructure that supports non-pharmacologic pain management in veterans and military service personnel.

02

Conditions studied

  • Chronic Pain

Browse trials for

03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Participants must meet the following inclusion criteria to be enrolled in the study:

  • Assigned to a VA PCP;
  • Report pain present every day or nearly every day for ≥ 6 months using a phone eligibility screener; and
  • PEG score of ≥ 5 (including at baseline assessment)

Exclusion criteria

Exclusion Criteria:

Candidates with any of the exclusion criteria at baseline will be excluded from study participation:

  • Moderate or severe cognitive impairment as determined by a failed 6-item, validated cognitive screener on initial phone screening (See Appendix A: Telephone Eligibility Screen/Script);
  • Active suicidality as determined by medical record review, standardized assessment (PHQ-9) and/or is unable to attend study visits because of an unstable or severe psychiatric or medical condition or is receiving palliative or hospice care; or
  • Any other factors that would interfere with study participation including inability to communicate by telephone, VTEL or VVC; being a non-English speaker; plans to relocate within 12 months and concurrent participation in another pain-related study.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
Single (Outcomes assessor)
Enrollment
793 participants (actual)

Study arms

  • Active comparator
    Whole Health Team (WHT) Intervention Arm

    The WHT intervention arm includes four core elements: 1) An interdisciplinary WHT collaborating with primary care; 2) Personalized Health Planning with prioritization of multi-modal non-pharmacological and CIH pain management approaches; 3) Whole Health Coaching sessions to assist patients in developing and implementing a Personalized Health Plan for chronic pain care; and 4) the web/mobile Whole Health Resource Directory provided to patient participants (in addition to their providers) to support non-pharmacologic/CIH chronic pain care.

    Behavioral: Whole Health Team (WHT) Intervention Arm, Primary Care Group Education (PC-GE) Intervention Arm, Usual Primary Care (UPC) Arm

  • Active comparator
    Primary Care Group Education (PC-GE) Intervention Arm

    Primary Care Group Education (PC-GE) is the comparator arm, which is an abbreviated form of Cognitive Behavioral Therapy for Chronic Pain (CBT-CP) adapted for group use in primary care.

    Behavioral: Whole Health Team (WHT) Intervention Arm, Primary Care Group Education (PC-GE) Intervention Arm, Usual Primary Care (UPC) Arm

  • Placebo comparator
    Usual Primary Care (UPC) Arm

    In VA, patient-aligned care teams (PACTs) or primary care is step 1 of VA's Stepped Care Model in the treatment of chronic pain. PCPs are expected to possess the requisite skill set for management of common chronic pain-causing conditions, which includes biopsychosocial assessment, multi-modal treatment, and coordination of specialty pain care after shared-decision making that incorporates patient preferences and values. Participants randomized to this arm will continue to have their PCP and PACT serve in this role.

    Behavioral: Whole Health Team (WHT) Intervention Arm, Primary Care Group Education (PC-GE) Intervention Arm, Usual Primary Care (UPC) Arm

Interventions

  • BehavioralWhole Health Team (WHT) Intervention Arm, Primary Care Group Education (PC-GE) Intervention Arm, Usual Primary Care (UPC) Arm

    Participants will be randomly assigned at the individual level to either WHT, PC-GE or Usual Primary Care, stratified by site, sex, and use of prescribed opioids for chronic pain. The follow-up period for the three arms will be 12 months. The primary outcome is change in pain interference. Secondary outcomes include change in pain intensity, functioning, quality of life, changes in use of pain medications, including opioids (if applicable) and changes in nonpharmacological pain self-management activities. After the baseline assessment, masked telephone assessments will be administered to participants at 3, 6, 9, and 12 months.

05

What researchers measure

Primary outcomes

  1. Change in Pain Interference

    The total Brief Pain Inventory (BPI) interference sub-scale score is our primary outcome measure. Pain interference was calculated as the mean of the 7 pain-interference items (scale ranged 0-10; higher scores indicate greater pain interference).

    Time frame: 12 months

Secondary outcomes

  1. Change in Pain Severity

    Change in pain severity was measured using the pain severity subscale from the Brief Pain Inventory (BPI). Pain severity was calculated as the mean of the 4 pain-severity items (scores ranged 0-10; higher scores indicate greater pain severity).

    Time frame: 12 months

  2. Functioning (VR-12 Physical Component Score)

    The investigators will assess functioning and quality of life using the THE VETERANS RAND 12-ITEM HEALTH SURVEY (VR-12). VR-12 scores were calculated using an algorithm provided by developers (available upon request). Functioning was determined using the physical component score. Subscales were developed to have a mean of 50 with a standard deviation of 10 in the reference population. Higher scores indicate better physical or mental functioning. Reported scores are adjusted means with corresponding standard errors, estimated using the LSMEANS statement in SAS 9.4 PROC GLIMMIX.

    Time frame: 12 months

  3. Quality of Life (VR-12 Mental Component Score)

    The investigators will assess functioning and quality of life using the THE VETERANS RAND 12-ITEM HEALTH SURVEY (VR-12). VR-12 scores were calculated using an algorithm provided by developers (available upon request). Quality of life was determined using the mental component score. Subscales were developed to have a mean of 50 with a standard deviation of 10 in the reference population. Higher scores indicate better physical or mental functioning. Reported scores are adjusted means with corresponding standard errors, estimated using the LSMEANS statement in SAS 9.4 PROC GLIMMIX.

    Time frame: 12 months

  4. PROMIS Sleep Disturbance

    The investigators will assess sleep and fatigue symptoms using the PROMIS - Sleep Disturbance. Sleep disturbance was scored as the sum of individual items, with items 2,3,7, and 8 reversed prior to summation (range 8-40; higher scores indicate greater sleep disturbance). The investigators will be screening for suicidality using the final question of the PHQ-9.

    Time frame: 12 months

  5. Engagement in a Greater Number of Non-pharmacological Pain Management Activities

    Past-year use of complementary therapies and self-management practices was measured using the Nonpharmacological and Self-Care Approaches from PMC (NSCAP). Categories of nonpharmacological activities included: 1. Acupuncture; 2. Manipulation; 3. Massage; 4. Yoga; 5. Tai Chi/Qigong; 6. Exercise; 7. Relaxation techniques; 8. Meditation/mindfulness; 9. Psychotherapy/counseling; or 10. Other. Each category was counted only once.

    Time frame: 12 months

  6. Suicidal Ideation

    Suicidal ideation was a single item analyzed as binary (yes/no) taken from the final question of the 9-item Patient Health Questionnaire (PHQ-9) which asked if participants have been bothered during the last 2 weeks by "Thoughts that you would be better off dead or of hurting yourself in some way." Values are reported from the 12-month assessment. The table indicates how many participants endorsed those thoughts "Several days", "More than half the days," and "Nearly every day" compared with "Not at all".

    Time frame: 12 months

  7. Decreased Use of Higher-risk Pain Medications, Including Opioids or High-risk Combinations of Pain Medications (i.e., Co-prescription of Opioids and Benzodiazepines)

    The investigators will utilize the VA administrative data/databases to obtain information on prescription medications, including generic name, dispensing information, dose, and instructions. Decreased opioid dose (Morphine Equivalent Daily Dose, MEDD) from baseline (binary: yes/no).

    Time frame: 12 months

  8. BPI Total Score

    The total BPI score was calculated as the mean of all 11 items (range 0-10; higher scores indicate greater overall pain).

    Time frame: 12 months

  9. Anxiety (GAD-7)

    Anxiety was measured using the Generalized Anxiety Disorder 7-item measure (GAD-7). This was scored as the sum of 7 items (range 0-21; higher scores indicate greater anxiety.)

    Time frame: 12 months

  10. Depression (PHQ-9)

    The Patient Health Questionnaire 9-item scale (PHQ-9) was used to measure depression. This was scored as the sum of 9 items (range 0-27; higher scores indicate greater depression).

    Time frame: 12 months

  11. Positive PTSD Screen (PC-PTSD-5)

    Positive PTSD (binary outcome) was determined using the Primary Care Post-traumatic Stress Disorder 5-item (PC-PTSD-5) measure. An endorsement (yes/no) of ≥ 3 items for women and ≥4 items for men indicated probable PTSD. The table indicates how many participants screened positive for PTSD.

    Time frame: 12 months

  12. Substance Use (TAPS-2)

    Substance use was measured using the Tobacco, Alcohol, and Substance Use (TAPS-2) tool. This outcome was binary (problem use was defined as 10+ cigarettes/day or any use within 30 minutes of waking). The table indicates how many participants were classified as having problematic substance use.

    Time frame: 12 months

  13. Patient Global Impression of Change (PGIC)

    The Patient Global Impression of Change (PGIC) scale was used to measure patients' impressions of study impact. The PGIC is a one-item measure that asks, "How would you describe your overall status now compared to when you started in our study?" Response options include: (3) Very Much Improved, (2) Much Improved, (1) Minimally Improved, (0) No Change, (-1) Minimally Worse, (-2) Much Worse, or (-3) Very Much Worse. Scores range from -3 to 3, with 0 indicating no improvement, and higher scores indicating more improvement in impression of change.

    Time frame: 12 months

  14. Alcohol Use (AUDIT-C)

    Alcohol problem use was measured using the Alcohol Use Disorders Identification Test Consumption (AUDIT-C). This scale contains 3 items which are added to yield scores with a range of 0-12, with higher scores indicating greater risk of high-risk alcohol use. Positive scores are defined using Version 3 cut-points of ≥ 3 for women and ≥ 4 for men. Scores for participants of all genders are reported in the table.

    Time frame: 12 months

06

Results

Posted Jun 2, 2026
Limitations and caveats
Generalizability of this study is limited to a veteran population that was predominantly White and male. Only a small proportion of those assessed for eligibility enrolled. There was unmeasured variability across sites that is inherent in pragmatic trial design. Clinicians and patients were not masked, and the patient-reported outcomes may have been influenced by patients' knowledge of group assignment. As a pragmatic trial, study group interventions were not balanced for time and attention.

Participant flow

Patients were identified for recruitment using the national VA EHR containing sociodemographic data. Other recruitment strategies included clinician and self-referrals. Potentially eligible patients were mailed study information.

Participant flow — Overall Study
MilestoneWhole Health Team (WHT) InterventionPrimary Care Group Education (PC-GE) InterventionUsual Care (UC)
Started34333982
Completed31630781
Not completed27321

Outcome measures

PrimaryChange in Pain Interference

The total Brief Pain Inventory (BPI) interference sub-scale score is our primary outcome measure. Pain interference was calculated as the mean of the 7 pain-interference items (scale ranged 0-10; higher scores indicate greater pain interference).

Time frame:
12 months
Reported as:
Least squares mean · scores on a scale
Change in Pain Interference
scores on a scaleWhole Health Team (WHT) Intervention ArmPrimary Care Group Education (PC-GE) Intervention ArmUsual Primary Care (UPC) Arm
Change in Pain Interference4.91 ± 0.165.49 ± 0.185.69 ± 0.20
Statistical analysis
  • Whole Health Team (WHT) Intervention Arm vs Primary Care Group Education (PC-GE) Intervention Arm · Regression, Linear · p = .02 (To control for multiple comparisons, P\<0.03 was used as a significance threshold for comparing whole health team vs. cognitive behavioral therapy.) · Mean difference (final values): -0.58 · 95% CI -1.11 to -0.05Values are differences in least-squares means.
  • Whole Health Team (WHT) Intervention Arm vs Usual Primary Care (UPC) Arm · Regression, Linear · p = .002 (To control for multiple comparisons, P\<0.01 as a significance threshold for comparisons of whole health team vs. usual care.) · Mean difference (final values): -0.77 · 95% CI -1.40 to -0.15Values are differences in least-squares means.
  • Primary Care Group Education (PC-GE) Intervention Arm vs Usual Primary Care (UPC) Arm · Regression, Linear · p = 0.46 (To control for multiple comparisons, P\<0.01 as a significance threshold for comparisons of cognitive behavioral therapy vs. usual care.) · Mean difference (final values): -0.19 · 95% CI -0.89 to 0.50Values are differences in least-squares means.
SecondaryChange in Pain Severity

Change in pain severity was measured using the pain severity subscale from the Brief Pain Inventory (BPI). Pain severity was calculated as the mean of the 4 pain-severity items (scores ranged 0-10; higher scores indicate greater pain severity).

Time frame:
12 months
Reported as:
Least squares mean · scores on a scale
Change in Pain Severity
scores on a scaleWhole Health Team (WHT) Intervention ArmPrimary Care Group Education (PC-GE) Intervention ArmUsual Primary Care (UPC) Arm
Change in Pain Severity5.05 ± 0.145.45 ± 0.185.63 ± 0.17
SecondaryFunctioning (VR-12 Physical Component Score)

The investigators will assess functioning and quality of life using the THE VETERANS RAND 12-ITEM HEALTH SURVEY (VR-12). VR-12 scores were calculated using an algorithm provided by developers (available upon request). Functioning was determined using the physical component score. Subscales were developed to have a mean of 50 with a standard deviation of 10 in the reference population. Higher scores indicate better physical or mental functioning. Reported scores are adjusted means with corresponding standard errors, estimated using the LSMEANS statement in SAS 9.4 PROC GLIMMIX.

Time frame:
12 months
Reported as:
Least squares mean · Scores on a scale
Functioning (VR-12 Physical Component Score)
Scores on a scaleWhole Health Team (WHT) Intervention ArmPrimary Care Group Education (PC-GE) Intervention ArmUsual Primary Care (UPC) Arm
Functioning (VR-12 Physical Component Score)28.55 ± 0.5327.75 ± 0.5128.08 ± 0.93
SecondaryQuality of Life (VR-12 Mental Component Score)

The investigators will assess functioning and quality of life using the THE VETERANS RAND 12-ITEM HEALTH SURVEY (VR-12). VR-12 scores were calculated using an algorithm provided by developers (available upon request). Quality of life was determined using the mental component score. Subscales were developed to have a mean of 50 with a standard deviation of 10 in the reference population. Higher scores indicate better physical or mental functioning. Reported scores are adjusted means with corresponding standard errors, estimated using the LSMEANS statement in SAS 9.4 PROC GLIMMIX.

Time frame:
12 months
Reported as:
Least squares mean · Scores on a scale
Quality of Life (VR-12 Mental Component Score)
Scores on a scaleWhole Health Team (WHT) InterventionPrimary Care Group Education (PC-GE) InterventionUsual Care (UC)
Quality of Life (VR-12 Mental Component Score)43.85 ± 0.7042.74 ± 0.7342.80 ± 1.15
SecondaryPROMIS Sleep Disturbance

The investigators will assess sleep and fatigue symptoms using the PROMIS - Sleep Disturbance. Sleep disturbance was scored as the sum of individual items, with items 2,3,7, and 8 reversed prior to summation (range 8-40; higher scores indicate greater sleep disturbance). The investigators will be screening for suicidality using the final question of the PHQ-9.

Time frame:
12 months
Reported as:
Least squares mean · scores on a scale
PROMIS Sleep Disturbance
scores on a scaleWhole Health Team (WHT) Intervention ArmPrimary Care Group Education (PC-GE) Intervention ArmUsual Primary Care (UPC) Arm
PROMIS Sleep Disturbance25.71 ± 0.4526.38 ± 0.4526.35 ± 0.65
SecondaryEngagement in a Greater Number of Non-pharmacological Pain Management Activities

Past-year use of complementary therapies and self-management practices was measured using the Nonpharmacological and Self-Care Approaches from PMC (NSCAP). Categories of nonpharmacological activities included: 1. Acupuncture; 2. Manipulation; 3. Massage; 4. Yoga; 5. Tai Chi/Qigong; 6. Exercise; 7. Relaxation techniques; 8. Meditation/mindfulness; 9. Psychotherapy/counseling; or 10. Other. Each category was counted only once.

Time frame:
12 months
Reported as:
Least squares mean · # of Nonpharmacological Approaches Used
Engagement in a Greater Number of Non-pharmacological Pain Management Activities
# of Nonpharmacological Approaches UsedWhole Health Team (WHT) Intervention ArmPrimary Care Group Education (PC-GE) Intervention ArmUsual Primary Care (UPC) Arm
Engagement in a Greater Number of Non-pharmacological Pain Management Activities3.67 ± 0.113.27 ± 0.123.03 ± 0.17
SecondarySuicidal Ideation

Suicidal ideation was a single item analyzed as binary (yes/no) taken from the final question of the 9-item Patient Health Questionnaire (PHQ-9) which asked if participants have been bothered during the last 2 weeks by "Thoughts that you would be better off dead or of hurting yourself in some way." Values are reported from the 12-month assessment. The table indicates how many participants endorsed those thoughts "Several days", "More than half the days," and "Nearly every day" compared with "Not at all".

Time frame:
12 months
Reported as:
Count of participants · Participants
Suicidal Ideation
ParticipantsWhole Health Team (WHT) InterventionPrimary Care Group Education (PC-GE) InterventionUsual Care (UC)
Positive: Several days or More14234
Negative: Not at all26524975
SecondaryDecreased Use of Higher-risk Pain Medications, Including Opioids or High-risk Combinations of Pain Medications (i.e., Co-prescription of Opioids and Benzodiazepines)

The investigators will utilize the VA administrative data/databases to obtain information on prescription medications, including generic name, dispensing information, dose, and instructions. Decreased opioid dose (Morphine Equivalent Daily Dose, MEDD) from baseline (binary: yes/no).

Time frame:
12 months
Reported as:
Count of participants · Participants
Decreased Use of Higher-risk Pain Medications, Including Opioids or High-risk Combinations of Pain Medications (i.e., Co-prescription of Opioids and Benzodiazepines)
ParticipantsWhole Health Team (WHT) Intervention ArmPrimary Care Group Education (PC-GE) Intervention ArmUsual Primary Care (UPC) Arm
Decreased opioid usage from baseline27 ± 9.733 ± 12.19 ± 11.4
Did not decrease opioid usage from baseline25224070
SecondaryBPI Total Score

The total BPI score was calculated as the mean of all 11 items (range 0-10; higher scores indicate greater overall pain).

Time frame:
12 months
Reported as:
Least squares mean · scores on a scale
BPI Total Score
scores on a scaleWhole Health Team (WHT) InterventionPrimary Care Group Education (PC-GE) InterventionUsual Care (UC)
BPI Total Score4.95 ± 0.145.55 ± 0.165.66 ± 0.16
SecondaryAnxiety (GAD-7)

Anxiety was measured using the Generalized Anxiety Disorder 7-item measure (GAD-7). This was scored as the sum of 7 items (range 0-21; higher scores indicate greater anxiety.)

Time frame:
12 months
Reported as:
Least squares mean · scores on a scale
Anxiety (GAD-7)
scores on a scaleWhole Health Team (WHT) Intervention ArmPrimary Care Group Education (PC-GE) Intervention ArmUsual Primary Care (UPC) Arm
Anxiety (GAD-7)6.12 ± 0.326.40 ± 0.377.01 ± 0.47
SecondaryDepression (PHQ-9)

The Patient Health Questionnaire 9-item scale (PHQ-9) was used to measure depression. This was scored as the sum of 9 items (range 0-27; higher scores indicate greater depression).

Time frame:
12 months
Reported as:
Least squares mean · scores on a scale
Depression (PHQ-9)
scores on a scaleWhole Health Team (WHT) InterventionPrimary Care Group Education (PC-GE) InterventionUsual Care (UC)
Depression (PHQ-9)8.96 ± 0.279.33 ± 0.269.21 ± 0.42
SecondaryPositive PTSD Screen (PC-PTSD-5)

Positive PTSD (binary outcome) was determined using the Primary Care Post-traumatic Stress Disorder 5-item (PC-PTSD-5) measure. An endorsement (yes/no) of ≥ 3 items for women and ≥4 items for men indicated probable PTSD. The table indicates how many participants screened positive for PTSD.

Time frame:
12 months
Reported as:
Count of participants · Participants
Positive PTSD Screen (PC-PTSD-5)
ParticipantsWhole Health Team (WHT) InterventionPrimary Care Group Education (PC-GE) InterventionUsual Care (UC)
Positive PTSD Screen (PC-PTSD-5)7910532
SecondarySubstance Use (TAPS-2)

Substance use was measured using the Tobacco, Alcohol, and Substance Use (TAPS-2) tool. This outcome was binary (problem use was defined as 10+ cigarettes/day or any use within 30 minutes of waking). The table indicates how many participants were classified as having problematic substance use.

Time frame:
12 months
Reported as:
Count of participants · Participants
Substance Use (TAPS-2)
ParticipantsWhole Health Team (WHT) InterventionPrimary Care Group Education (PC-GE) InterventionUsual Care (UC)
Substance Use (TAPS-2)35327
SecondaryPatient Global Impression of Change (PGIC)

The Patient Global Impression of Change (PGIC) scale was used to measure patients' impressions of study impact. The PGIC is a one-item measure that asks, "How would you describe your overall status now compared to when you started in our study?" Response options include: (3) Very Much Improved, (2) Much Improved, (1) Minimally Improved, (0) No Change, (-1) Minimally Worse, (-2) Much Worse, or (-3) Very Much Worse. Scores range from -3 to 3, with 0 indicating no improvement, and higher scores indicating more improvement in impression of change.

Time frame:
12 months
Reported as:
Least squares mean · scores on a scale
Patient Global Impression of Change (PGIC)
scores on a scaleWhole Health Team (WHT) InterventionPrimary Care Group Education (PC-GE) InterventionUsual Care (UC)
Patient Global Impression of Change (PGIC)0.95 ± 0.090.75 ± 0.100.30 ± 0.15
SecondaryAlcohol Use (AUDIT-C)

Alcohol problem use was measured using the Alcohol Use Disorders Identification Test Consumption (AUDIT-C). This scale contains 3 items which are added to yield scores with a range of 0-12, with higher scores indicating greater risk of high-risk alcohol use. Positive scores are defined using Version 3 cut-points of ≥ 3 for women and ≥ 4 for men. Scores for participants of all genders are reported in the table.

Time frame:
12 months
Reported as:
Least squares mean · scores on a scale
Alcohol Use (AUDIT-C)
scores on a scaleWhole Health Team (WHT) InterventionPrimary Care Group Education (PC-GE) InterventionUsual Care (UC)
Alcohol Use (AUDIT-C)1.36 ± 0.091.20 ± 0.081.37 ± 0.19

Adverse events

Collected over From enrollment until end of follow-up, up to 410 days.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Whole Health Team (WHT) Intervention Arm1/343 (0.3%)78/343 (22.7%)164/343 (47.8%)
Primary Care Group Education (PC-GE) Intervention Arm1/339 (0.3%)57/339 (16.8%)160/339 (47.2%)
Usual Primary Care (UPC) Arm1/82 (1.2%)18/82 (22%)38/82 (46.3%)
Most frequent serious events
Most frequent serious events
EventWhole Health Team (WHT) Intervention ArmPrimary Care Group Education (PC-GE) Intervention ArmUsual Primary Care (UPC) Arm
HospitalizationGeneral disorders78/34357/33918/82
Most frequent other events
Most frequent other events
EventWhole Health Team (WHT) Intervention ArmPrimary Care Group Education (PC-GE) Intervention ArmUsual Primary Care (UPC) Arm
Emergency Department VisitGeneral disorders164/343160/33938/82

Baseline characteristics

Age, Continuous
Age, Continuous(Year)Whole Health Team (WHT) Intervention ArmPrimary Care Group Education (PC-GE) Intervention ArmUsual Primary Care (UPC) ArmTotal
Mean60.2 ± 12.860.7 ± 11.860.4 ± 12.160.5 ± 12.3
Sex/Gender, Customized
Sex/Gender, Customized(Participants)Whole Health Team (WHT) Intervention ArmPrimary Care Group Education (PC-GE) Intervention ArmUsual Primary Care (UPC) ArmTotal
Male23222353508
Female11111629256
Non-Binary/Third gender0000
Prefer to self-describe0000
Transgender47011
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Whole Health Team (WHT) Intervention ArmPrimary Care Group Education (PC-GE) Intervention ArmUsual Primary Care (UPC) ArmTotal
American Indian or Alaska Native3519
Asian710017
Native Hawaiian or Other Pacific Islander2507
Black or African American728019171
White21119654461
More than one race3329466
Unknown or Not Reported1514433
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Whole Health Team (WHT) Intervention ArmPrimary Care Group Education (PC-GE) Intervention ArmUsual Primary Care (UPC) ArmTotal
Hispanic or Latino474213102
Not Hispanic or Latino29029568653
Unknown or Not Reported6219
Pain Interference (BPI)
Pain Interference (BPI)(scores on a scale)Whole Health Team (WHT) Intervention ArmPrimary Care Group Education (PC-GE) Intervention ArmUsual Primary Care (UPC) ArmTotal
Mean6.6 ± 1.96.4 ± 1.96.4 ± 1.86.5 ± 1.9
Opioid use at time of enrollment
Opioid use at time of enrollment(Participants)Whole Health Team (WHT) Intervention ArmPrimary Care Group Education (PC-GE) Intervention ArmUsual Primary Care (UPC) ArmTotal
No opioid usage25525560570
Opioid usage888422194
07

Study locations

6 sites
  • SFVAHCS
    San Francisco, California 94121, United States
  • VA Connecticut
    West Haven, Connecticut 06516, United States
  • James A. Haley Veterans Hospital
    Tampa, Florida 33612, United States
  • Bedford VAMC
    Bedford, Massachusetts 01730, United States
  • VA St. Louis Health Care System
    St Louis, Missouri 63125, United States
  • VAPHCS
    Portland, Oregon 97239, United States
08

References and documents

Publications

  • Purcell N, Becker WC, Zamora KA, McGrath SL, Hagedorn HJ, Fabian ER, McCamish N, Seal KH. Tailored to Fit: How an Implementation Framework Can Support Pragmatic Pain Care Trial Adaptation for Diverse Veterans Affairs Clinical Settings. Med Care. 2020 Sep;58 Suppl 2 9S(Suppl 2 9 Suppl):S80-S87. doi: 10.1097/MLR.0000000000001376. PubMed 32826776 ↗
  • Tong G, Seal KH, Becker WC, Li F, Dziura JD, Peduzzi PN, Esserman DA. Impact of complex, partially nested clustering in a three-arm individually randomized group treatment trial: A case study with the wHOPE trial. Clin Trials. 2022 Feb;19(1):3-13. doi: 10.1177/17407745211051288. Epub 2021 Oct 24. PubMed 34693748 ↗
  • Seal KH, Becker WC, Murphy JL, Purcell N, Denneson LM, Morasco BJ, Martin AM, Reddy K, Iseghem TV, Krebs EE, Painter JM, Hagedorn H, Pyne JM, Hixon J, Maguen S, Neylan TC, Borsari B, DeRonne B, Gibson C, Matthias MS, Frank JW, Krishnaswamy A, Li Y, Bertenthal D, Chan A, Nunez A, McCamish N. Whole Health Options and Pain Education (wHOPE): A Pragmatic Trial Comparing Whole Health Team vs Primary Care Group Education to Promote Nonpharmacological Strategies to Improve Pain, Functioning, and Quality of Life in Veterans-Rationale, Methods, and Implementation. Pain Med. 2020 Dec 12;21(Suppl 2):S91-S99. doi: 10.1093/pm/pnaa366. PubMed 33313734 ↗
  • Seal KH, Feinberg T, Moore L, Woodruff NA, Purcell N, Bertenthal D, McCamish N, Becker WR. Natural Product Use for Chronic Pain: A New Survey of Patterns of Use, Beliefs, Concerns, and Disclosure to Providers. Glob Adv Integr Med Health. 2025 Feb 27;14:27536130251320101. doi: 10.1177/27536130251320101. eCollection 2025 Jan-Dec. PubMed 40026674 ↗
  • Moore LC, Woodruff NA, Seal KH, Feinberg T, Purcell N. Natural Product Use Among Veterans with Chronic Pain: A Qualitative Study of Attitudes and Communication with Healthcare Providers. J Gen Intern Med. 2024 Sep;39(12):2206-2214. doi: 10.1007/s11606-024-08746-2. Epub 2024 Apr 30. PubMed 38689119 ↗
  • Denneson LM, Purcell N, McGrath SL, Abadjian LR, Becker WC, Seal KH. Integration of Health Coaches in a Whole Health Team Model of Chronic Pain Care: a Qualitative Study. J Gen Intern Med. 2023 Dec;38(16):3574-3580. doi: 10.1007/s11606-023-08317-x. Epub 2023 Jul 18. PubMed 37464147 ↗
  • Seal KH, Morasco BJ, Martin AM, Reddy KP, Van Iseghem TM, Bolton RE, Bokhour BG, Murphy J, Denneson LM, Esserman D, Buta E, Purcell N, Bertenthal D, Painter JT, Abadjian LR, Moore LC, Chan AC, McCamish N, Maguen S, Neylan TC, Gibson CJ, Becker WC; wHOPE Study Group. The Veterans Affairs' Whole Health Approach for Chronic Pain Management: The wHOPE Randomized Clinical Trial. JAMA. 2026 May 26;335(20):1774-1786. doi: 10.1001/jama.2026.5006. PubMed 42054020 ↗

Study documents

  • Study protocol · May 22, 2025
  • Statistical analysis plan · Nov 20, 2024
  • Informed consent form · Jun 17, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Registry details

Key details

Study ID
NCT04330365
Lead sponsor
San Francisco Veterans Affairs Medical Center
Collaborators
National Center for Complementary and Integrative Health (NCCIH)
Responsible party
Karen Seal (Chief of Integrative Medicine, San Francisco Veterans Affairs Medical Center) — Principal investigator
First posted
Apr 1, 2020
Start date
Sep 15, 2020
Primary completion
Jan 23, 2025
Completion
Jan 23, 2025
Results posted
Jun 2, 2026
Last update
Jun 2, 2026

Study contacts

Karen H Seal, MD
principal investigator · San Francisco VA Health Care System

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion